EcoDrugPlus

Toll Like Receptor 2

Ensembl ID : ENSMZEG00005011375
Gene Symbol: TLR2
4 Cross references
170 Possible Orthologues:

Toll-Like Receptor 2

Ensembl ID : ENSMZEG00005027830
Gene Symbol: LOC101470585
3 Cross references
213 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSMZEG00005026466
Gene Symbol: TAAR1
2 Cross references
428 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSMZEG00005014950
Gene Symbol: TAAR1
1 Cross references
347 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSMZEG00005021515
Gene Symbol: TRPA1
3 Cross references
200 Possible Orthologues:

Tryptophan 5-Hydroxylase 1-Like

Ensembl ID : ENSMZEG00005002263
Gene Symbol: LOC101484460
3 Cross references
176 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSMZEG00005001939
Gene Symbol: TPH1
3 Cross references
207 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSMZEG00005009972
Gene Symbol: TUBA4A
3 Cross references
153 Possible Orthologues:

Tubulin Alpha Chain

Ensembl ID : ENSMZEG00005009961
Gene Symbol: LOC101475575
3 Cross references
151 Possible Orthologues:

Tubulin Alpha Chain

Ensembl ID : ENSMZEG00005024512
Gene Symbol: LOC112435909
2 Cross references
308 Possible Orthologues:

Tubulin Alpha-1b Chain

Ensembl ID : ENSMZEG00005022306
Gene Symbol: LOC101472165
2 Cross references
188 Possible Orthologues:

Tubulin Alpha-1c Chain

Ensembl ID : ENSMZEG00005015539
Gene Symbol: LOC101486701
2 Cross references
170 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).